Jane N. Winter, MD, professor of medicine, Division of Hematology/Oncology, Northwestern University, discusses the ZUMA-7 trial (NCT03391466) in diffuse large B-cell lymphoma (DLBCL).
Jane N. Winter, MD
Advertisement
Articles by Jane N. Winter, MD
Jane N. Winter, MD, professor of medicine, Division of Hematology/Oncology, Northwestern University, discusses copanlisib (Aliqopa) in follicular lymphoma.
Jane N. Winter, MD, professor of medicine, Feinberg School of Medicine, Northwestern University, discusses checkpoint inhibitors for Hodgkin lymphoma.
Jane N. Winter, MD, professor of medicine, Division of Hematology/Oncology, Northwestern University, discusses the promise of chimeric antigen receptor (CAR) T-cell therapy in hematologic malignancies.
Jane N. Winter, MD, professor of medicine, Division of Hematology/Oncology, Northwestern University, discusses response in follicular lymphoma.
Advertisement
Latest Updated Articles
Dr. Winter on the Promise of CAR T-Cell Therapy in Hematologic MalignanciesPublished: October 11th 2017 | Updated:
Dr. Winter on Checkpoint Inhibitors for Hodgkin LymphomaPublished: October 25th 2017 | Updated:
Dr. Winter Discusses Copanlisib in Follicular LymphomaPublished: November 18th 2017 | Updated:
Dr. Winter Discusses the ZUMA-7 Trial in DLBCLPublished: March 27th 2018 | Updated:
Dr. Winter Discusses Response in Follicular LymphomaPublished: October 8th 2017 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
Oncology Fellows Presents a New Drug Cheat Sheet for Fellows
3
Third NDA for Rivoceranib/Camrelizumab Is Resubmitted to FDA for Unresectable HCC
4
Northwestern Medicine Surgeons Develop a Total Artificial Lung System to Keep a Patient Alive for 48 Hours After Removing Both Lungs, Enabling a Double-Lung Transplant
5